Xenon Pharmaceuticals Inc. Income Statement
XENE / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 1.7% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $15.6M | $1.8M | $15.6M | $14.3M | $27.4M | $14.3M |
| SG&A Expense | $79.6M | $68.9M | $46.5M | $32.8M | $22.0M | $12.9M | $10.8M | $8.4M | $9.8M | $6.8M | $9.8M | $7.0M | $5.3M | $7.0M |
| R&D Expense | $300.9M | $210.4M | $167.5M | $105.8M | $75.5M | $50.5M | $38.8M | $23.6M | $15.2M | $19.8M | $15.2M | $10.5M | $12.3M | $10.5M |
| Operating Income | -$373.1M | -$279.3M | -$214.1M | -$129.1M | -$79.0M | -$31.3M | -$42.8M | -$38.0M | -$9.4M | -$24.8M | -$9.4M | -$3.2M | $9.7M | -$3.2M |
| Interest Expense | - | - | - | - | - | $484.0K | $1.4M | $1.4M | - | - | - | $93.0K | $64.0K | $93.0K |
| Income Tax | $1.0M | -$4.1M | -$292.0K | $118.0K | -$6.0K | -$257.0K | -$23.0K | -$24.0K | - | - | - | $0 | $0 | $0 |
| Net Income | -$345.9M | -$234.3M | -$182.4M | -$125.4M | -$78.9M | -$28.8M | -$41.6M | -$34.5M | -$15.8M | -$23.0M | -$15.8M | -$4.3M | $12.0M | -$4.3M |
| EPS (Basic) | -$4.36 | -$3.01 | -$2.73 | -$2.06 | -$1.77 | -$0.81 | - | -$1.71 | -$1.10 | $4.11 | $2.87 | -$3.24 | $2.87 | -$3.24 |
| EPS (Diluted) | -$4.36 | -$3.01 | -$2.73 | -$2.06 | -$1.77 | -$0.81 | - | -$1.72 | -$1.10 | $3.28 | $1.91 | -$3.24 | $1.91 | -$3.24 |
| Shares Outstanding | 79.3M | 77.9M | 66.9M | 60.5M | 43.6M | 34.5M | 25.9M | 18.0M | 17.9M | 14.4M | 14.2M | 1.3M | 2.0M | 1.3M |
| Operating Margin | - | - | - | - | - | - | - | - | -60.1% | -1376.4% | -60.1% | -22.0% | 35.5% | -22.0% |
| Profit Margin | - | - | - | - | - | - | - | - | -101.1% | -1275.5% | -101.1% | -30.1% | 44.0% | -30.1% |